[ad_1]
This cohort study examines successful direct-acting antiviral treatment and the risk of extrahepatic manifestations among individuals with chronic hepatitis C virus infections from 1990 to 2021.
[ad_2]
Source link
[ad_1]
This cohort study examines successful direct-acting antiviral treatment and the risk of extrahepatic manifestations among individuals with chronic hepatitis C virus infections from 1990 to 2021.
[ad_2]
Source link